Table Of Contents:

Chapter 1. Research Methodology and Scope

• • Market Segmentation and Scope
  • Regional Coverage
  • Objectives (1,2,3)
  • Research Methodology

Chapter 2. Executive Summary

• • Market Landscape
  • Market Size & Forecast
  • Competitive Landscape

Chapter 3. Genital Herpes Market: By Type Market Trends, Size, and Future Outlook

• • By Type Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • By Type Definitions, Technology Landscape
  • By Type Market Drivers
    • Product Launches
    • Technology Launches
    • Rising prevalence of HSV-1 and HSV-2 infections
  • By Type Market Restraints
    • Social stigmS
    • a surrounding genital herpes
    • Long duration of clinical trials

Chapter 4. Genital Herpes Market: By Drug Class Market Trends, Size, and Future Outlook

• • By Drug Class Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • By Drug Class Definitions, Technology Landscape
  • By Drug Class Market Drivers
    • Strong pipeline of novel antiviral drugs
    • Approvals of drugs like pritelivir, brincidofovir etc.
  • By Drug Class Market Restraints
    • Concerns regarding side effects of antiviral medications

Chapter 5. Genital Herpes Market: By Route of Administration Market Trends, Size, and Future Outlook

• • By Route of Administration Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • By Route of Administration Definitions, Technology Landscape
  • By Route of Administration Market Drivers
    • Rising adoption of OTC topical medications
    • Increase in oral antiviral prescribing
  • By Route of Administration Market Restraints
    • Low adherence to treatment regimens

Chapter 6. Genital Herpes Market: By Distribution Channel Market Trends, Size, and Future Outlook

• • By Distribution Channel Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • By Distribution Channel Definitions, Technology Landscape
  • By Distribution Channel Market Drivers
    • High prescription rates in hospitals and clinics
    • Rising online pharmacies and e-commerce
  • By Distribution Channel Market Restraints
    • Prescription only status of branded antivirals

Chapter 7. Genital Herpes Market: Regional Market Trends, Size, and Future Outlook

• • North America Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • North America Definitions, Technology Landscape
  • North America Market Drivers
    • High disease prevalence and awareness
  • North America Market Restraints
    • Patent expiry of leading brands
  • Competitive Outlook
  • Europe Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • Europe Definitions, Technology Landscape
  • Europe Market Drivers
    • Improving access to screening and diagnosis
  • Europe Market Restraints
    • Stigma regarding STIs
  • Competitive Outlook
  • Asia Pacific Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • Asia Pacific Definitions, Technology Landscape
  • Asia Pacific Market Drivers
    • Large patient pool and unmet need
  • Asia Pacific Market Restraints
    • Lack of awareness in some countries
  • Competitive Outlook
  • Rest of the World Market Size (US$), CAGR (%), and Forecast (2022-2030)
  • Rest of the World Definitions, Technology Landscape
  • Rest of the World Market Drivers
    • Rising efforts to control STIs
  • Rest of the World Market Restraints
    • Limited access to healthcare
  • Competitive Outlook

Chapter 8. Genital Herpes Market: Competitive Landscape

• GlaxoSmithKline
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Merck & Co.
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Abbott
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Becton, Dickinson and Company (BD)
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Danaher
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Thermo Fisher Scientific
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• F. Hoffmann-La Roche
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Diasorin
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Quidel
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Siemens Healthineers
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Hologic
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Cepheid
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Trinity Biotech
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Abcam
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• BioMerieux
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Teco Diagnostics
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Abott Laboratories
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Bundi International Diagnostics
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Chrono-Log Corp
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Corgenix
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies
• Other major companies
  • • Company Overview
    • Financial Outlook
    • Product Portfolio
    • Strategies

Research Methodology

• • Primary Research
  • Secondary Research
  • Assumptions
  • IDataAcumen Analysis
  • Paid Databases

Appendix

About Us